A prospective survey of one thousand and sixty-two patients receiving epidural analgesia in surgical wards was undertaken over a two-year period. The duration of infusion ranged from one to fourteen days, with a mode of three days. There were 1131 episodes where a local anaesthetic and opioid mixture was used and 160 where opioids were used alone. Local anaesthetic was not used without opioids. 23% of catheters were removed prematurely because of catheter related problems including accidental dislodgement (13%) and skin site inflammation (5.3%). No epidural abscess or haematoma was identified. In 14% of the total number of episodes there was either no demonstrable block or complications occurred requiring a change of solution: 30% of this group were salvaged following intervention by the Acute Pain Service (APS). The incidence of respiratory depression was 0.24%. There was no case of delayed respiratory depression. Epidural analgesia can be used safely in surgical wards provided that regular review of the patients is undertaken. It must be anticipated however, that up to 20% of patients will not receive adequate analgesia for the first 48 hours postoperatively. The failure rate could be halved if accidental dislodgement of epidural catheters could be eliminated.
There is evidence to support the use of epidural analgesia for a wide variety of postoperative patients. For some of these patients the technique has been shown to have benefits over conventional intramuscular opioid analgesia and patient controlled analgesia using opioids [1] [2] [3] [4] .
There are however, few large series which give some indication of the side-effects and complications when this form of analgesia is applied to the surgical population in a ward-based setting. The concept of the Acute Pain Service (APS) has now been widely accepted, and dedicated pain services have been established in many locations. This has allowed the safe implementation of epidural techniques, and has also provided the opportunity to collect data on a large numbers of patients receiving epidural analgesia. Our aim was to evaluate side-effects and complications in over 1,000 patients receiving epidural analgesia in surgical wards. Our institution is a tertiary level teaching hospital with about 150 surgical beds and in which about 11,000 procedures are performed annually.
MATERIALS AND METHODS
Data were prospectively collected from 1062 sequential patients who received epidural analgesia either postoperatively or following trauma, and were cared for in general surgical wards. No other selection criteria were used. Some patients spent part of their time in ICU, but only for indications unconnected with the use of epidural analgesia.
Epidural catheters were inserted in the operating theatre or recovery room by specialist anaesthetists or anaesthetic registrars. The expressed aim was to insert catheters in the mid-dermatomal level for the area to be blocked, except for those intended for morphine infusion which were all inserted below L1/L2. Portex 18-gauge catheters (Boots Co. Aust. Pty Ltd) were used for all adult patients and 24-gauge catheters for patients weighing less than 10 kg. Bupivacaine 0.125% or 0.25% with fentanyl 1.0 to 5 µg/ml was infused from Astra Polybags (Astra Pharmaceuticals Sydney, N.S.W.) via an AVI pump (3M, St Paul, MN, U.S.A.) and an 8C390 giving set which contains no injection ports. All other solutions were infused via IVAC 711 pump and IVAC G30402 giving set which again has no injection ports (IVAC Corp., San Diego, CA). Morphine infusions contained 5 mg in 50 ml.
The choice of the initial concentration of local anaesthetic and fentanyl was made by the individual inserting the epidural catheter, but was modified by the APS when either quality or extent of blockade was inadequate, or sedation or motor block was excessive. All solutions requiring mixing, dilution or addition of drugs were prepared in the ward environment by nursing staff in accordance with APS protocols.
Adjuvant analgesic agents, where used, were prescribed by the APS. On occasions other solutions were used where they were judged to be indicated by the APS consultant. Orders for all infusions were written on a dedicated APS epidural infusion chart detailing standard solutions, observations and standing orders. Instructions for the preparation of solutions, management of complications and administration of bolus doses are included on this chart.
Standing orders allow registered nursing staff to administer a single bolus dose as ordered by the anaesthetist, with review by the APS when adequate analgesia was not achieved. APS strategies for improving such blocks were not standardized.
Catheters were fixed to the skin using a combination of transparent occlusive dressings, either Opsite (Smith and Nephew, Ryde, Sydney, N.S.W.) or Tegederm (3M), with Steristrips (3M, Pymble, Sydney, N.S.W.). Hyperfix (Smith and Nephew, Ryde, Sydney, N.S.W.) tape surrounded the occlusive dressing and fixed the catheter to the patient's back. Dressings were not changed unless fluid was collecting underneath or they were coming loose. Towards the end of the data collection period subcutaneous tunnelling was used in some patients in an attempt to reduce the rate of accidental dislodgement of catheters.
All data were collected by the APS as part of the daily ward rounds performed at 8 am and 3 pm. Any attendance outside these rounds was also recorded. Data recorded included demographic data for each patient and the surgical site. The infusion type and location of the catheter (either thoracic or lumbar) were recorded and all complications were noted.
Patients were asked to verbally score their pain on a numeric scale from 0 to 5, where 0=no pain, and 5=the worst pain imaginable. Analgesia was deemed to be sufficient when the pain scores recorded by the nursing staff were consistently<2/5, and in addition at the time of the APS round the patient was recorded as able to breathe deeply and cough in the case of abdominal or thoracic sites of pain, or to move the affected limb without pain in the case of more peripheral lesions. This admittedly nonstandardized test was considered to be a more useful assessment of analgesia than a single VAS or other pain score, as it is more closely aligned to the desirable clinical endpoint.
Routine observations recorded by ward nursing staff were sedation score, subjective pain score (fivepoint verbal numeric scale), pulse rate, blood pressure, temperature, oxygen saturation and degree of motor block. Oximetry was not used continuously, and supplemental oxygen was used only where indicated by spot oximetry. Administrations of epidural bolus doses, antiemetic or naloxone were also recorded. The frequency of observations was hourly for six hours after the establishment of blockade or administration of a bolus dose, and thence second hourly.
Definitions
Each patient received one or more episodes of epidural analgesia. A new episode was recorded when either the catheter was replaced or the solution changed. An episode was coded as a failure when a change of analgesic technique or solution was required because either the analgesia produced was insufficient or side-effects occurred which were unacceptable to either the patient or the APS.
Sedation was defined as excessive when the sedation score was >2 on the following scale: 3=difficult to arouse; 2=frequently drowsy, easy to arouse; 1=occasionally drowsy, easy to rouse; 0=awake/ alert; S=sleeping, easy to arouse. Naloxone was given if the patient was unresponsive to verbal stimulation, or at the discretion of the APS staff.
Respiratory depression was defined as a respiratory rate of <8 breaths/minute in the presence of excessive sedation. Naloxone was ordered in 100 µg aliquots intravenously each two minutes if the patient was unresponsive to verbal stimulation. An infusion of naloxone at 1 to 2 µg/kg/h was available by consultation with the APS if required.
Hypotension was defined as a systolic BP of <90 mmHg or a fall of >25% of normal systolic BP.
Nausea and vomiting were recorded as a sideeffect when more than one dose of antiemetic drug was required.
Skin site inflammation was defined as an area of erythema of >5 mm or the presence of induration or discharge from the catheter site. All catheters were withdrawn when any of these findings were made, and tips were cultured if discharge was seen. Further investigation and or management was undertaken on clinical suspicion and antibiotics were used only when recommended by the Infectious Diseases Unit on either clinical or microbiological grounds.
Prolonged block was defined as sensory and/or motor blockade persisting for >6 hours after cessation of the infusion.
High block was defined as a block more than two dermatomes above the target level as measured by loss of cold sensation to ice.
Ward error was recorded for mistakes made in either the preparation of the infusions or the process of their administration.
Leg weakness was defined as a Modified Bromage Score of 4 (detectable weakness of hip flexion) or less.
Analysis
Data were stored in a relational database 4D First for Macintosh (ACI) and analysed using Statview (Abacus Concepts Inc) and Excel (Microsoft). Contingency tables and the chi squared test were applied in the analysis of nonparametric data.
RESULTS
Data were collected from all patients seen by the APS from August 1994 to October 1996 where epidural analgesia was employed. During this time 1062 the patients received epidural analgesia in 1291 episodes, indicating that either catheters were replaced or that a different solution was required to optimize analgesia.
Patient age ranged from six weeks to 92 years, with a median of 65.5 years. There were 1131 episodes where a local anaesthetic and opioid mixture was used and 160 where opioids were used alone. In total, the number of episodes of epidural analgesia at each site was 805 thoracic, 485 lumbar and one cervical.
The infusions were continued for between one and 15 days, with a mean duration of 2.7 days and a mode of 3 days ( Figure 1 ).
The 77 patients who received epidural infusions for longer than five days came from the following surgical groups: general surgery (29), gynaecology (15) , vascular surgery (15) , thoracic surgery (7), nonoperative (6), orthopaedics (3), and urology (2) . The solutions used are shown in Table 1 . The types of surgery performed are shown in Table 2 .
A total of 89 patients received adjunctive treatment: 64 received paracetamol±codeine, 10 NSAIDs, 7 epidural clonidine, 4 anticonvulsants, 3 oral opioids, and 1 a tricyclic antidepressant.
For the purposes of presentation the complications have been assigned as either catheter-related, or technique-related, with the latter divided into minor and major.
Catheter-related complications
1062 catheters were placed during the study period, with 10 patients having had epidural catheters replaced by the APS after leaving the recovery unit. It should be noted that only patients with an epidural which was assessed as functioning at the time of leaving recovery were studied. This survey does not include patients whose epidurals were recognized to have failed prior to discharge from the recovery ward, or those in whom attempts to insert a catheter in the operating theatre were unsuccessful. Table 3 indicates the catheter-related complications observed.
The timing of catheter dislodgement and site inflammation with respect to catheter insertion is shown in Figures 2 and 3 .
There was a highly significant difference in the incidence of site inflammation between a catheter left in situ for three days or less, compared to those left for four or more days (P<0.001). Sixteen catheter tips were sent for culture, from which six positive cultures were obtained. Five patients were prescribed antibiotics by the Infectious Diseases Unit for site inflammation, two on day 2, one on day 4, and two on day 5. There was no significant difference between the groups <4 days and >4 days with respect to requirement for antibiotics.
Technique-related complications
Pruritus, nausea and vomiting, hallucination, high block, prolonged block and dural tap were designated as minor complications ( Table 4 ), in that they usually do not pose a serious risk to the patient, although it is recognised that these problems are not trivial. Because most patients had an indwelling urinary catheter, the frequency of urinary retention could not be determined.
Failure, hypotension, cardiac arrest, respiratory depression, sedation, requirement for naloxone, nursing errors, prolonged blockade and post dural puncture headache were designated as major complications of technique ( Abbreviations: L Abdo=lower abdomen, U Abdo=upper abdomen, U+L Abdo=upper and lower abdomen. The three main solutions were also analysed with respect to side-effects which may have been related to the infusion chosen (Table 6) .
DISCUSSION
There is evidence in the literature that epidural analgesia can provide better pain relief than conventional opioid techniques 1-3 . This is particularly evident when analgesia is provided by local anaesthetics and opioids together, and is best demonstrated when the patient is not at rest but is stressed by moving or coughing 4, 5 . Both the ability to cough and to move freely are in themselves desirable clinical endpoints for any analgesic technique in the postoperative period.
However, few references give insight into the success rate of such strategies, in particular the use of bupivacaine and opioids used in combination. The setting of the controlled trial, where strategies for defining and managing complications are rigidly defined, may not reflect the reality of working APS units. Furthermore as many complications are quite rare, it is only in large series that an idea of their true prevalence begins to emerge, and some indeed are so uncommon that this can only be achieved by techniques such as meta analysis.
Our study defined failure as any complication requiring a change in either infusion mixture or technique. This occurred in 14% of epidural infusion episodes. Furthermore 23% of catheters inserted were removed prematurely because of catheterrelated problems, mainly accidental dislodgement (13%) and site inflammation (5.3%). In the 14% of episodes in which failure occurred, one third of these were able to be converted to satisfactory blocks after the intervention of the APS. The remaining 10% either had their catheter replaced or were prescribed an alternative analgesic technique.
The percentage salvaged was higher in the earlier part of the study, reflecting a lack of awareness amongst the anaesthetists of avoidable complications, in particular the production of excessive motor block by the use of 0.25% bupivacaine which was the standard solution prior to the introduction of the APS. In the last 10 months the proportion of cases which could be salvaged fell to 15%. This compares favourably with the study of Scott, Beilby and McClymont 6 who, using bupivacaine and fentanyl infusions only, found that 11% of their infusions were terminated prematurely because of either inadequate relief (7.6%) or side-effects (4.4%). Of their epidurals 18% were ceased because of either catheter dislodgement (12.6%) or other mechanical problems (6.1%). de Leon-Casasola 7 , with his very large group of postoperative cancer patients receiving bupivacaine and morphine infusions, reported an epidural catheter failure rate of 6.3% and a 1.6% accidental catheter removal rate. Schug reviewed 919 patients retrospectively who were receiving epidural analgesia, and as part of a comparison with intravenous opioids then randomly selected 170 patients. He reported a 15.5% requirement for boluses to maintain analgesia and a 2.4% incidence of abandonment of the technique because of failure. The catheter was dislodged before the planned end of treatment in 5% of patients 8 .
Accidental removal of epidural catheters is thus a consistently reported problem which has a major impact on the ability to provide consistent analgesia using epidurals. The fact that in our study the majority of these occurred early in the course of treatment is of great concern, because this is the very time in which the greatest benefit to the patient may be expected from epidural analgesia.
Catheter migration has long been recognized in obstetric patients, with up to 50% of catheters moving from their original position 9 . It has also been documented in thoracic epidurals used for postoperative 169 analgesia 10 . Various methods have been described to try to reduce this problem, including the use of a variety of dressings ("Mefix" 4 , "Mefix" and "Duoderm" 10 , "Opsite" 11 ) and subcutaneous tunnelling 13, 14 . We have been unwilling to use dressings which obscure the insertion site, because of concerns about the incidence of site inflammation. We are currently conducting a controlled trial of subcutaneous tunnelling versus the fixation method described above.
In our study the incidence of site inflammation was 5.3%, compared with 3.8% in Scott's paper 6 and 0.57% in de Leon-Casasola's series 7 . There was no case of epidural abscess in our study period, compared with one in de Leon-Casasola's 7 . Schug 8 did not define catheter infection, but found a zero incidence in 919 patients when all catheters were in situ for an average of more than three days.
Our survey found a highly significant increase in site inflammation for catheters in place for four or more days. Seventy-four per cent of the 31 cases of site inflammation occurred on or after day 4.
One patient, an elderly diabetic female, was discharged from hospital with no apparent problems, after having had an epidural catheter for three days following a vascular procedure. She then presented to hospital with back pain thirteen days after the procedure and was found to have an inflammatory site deep to the skin and around the epidural puncture track. There was no neurological impairment and no evidence of infection deep to the ligamentum flavum. She was treated with antibiotics but not surgery and the symptoms resolved.
While it is true that in comparison with other published studies 7, 8 we reported a higher incidence of catheter site inflammation, there was no episode of infection within the epidural space in our series. Positive cultures were obtained from six catheters; however, only 16 were sent for culture, as this was only performed when clinically indicated.
The differences in site inflammation rates may reflect the use of different dressing techniques, skin preparation techniques or climatic conditions as well as patient and surgical factors. Sakuragi has noted a marked difference in the duration of skin disinfection depending on the season (summer vs winter) and the disinfectant used. He recommended the use of chlorhexidine in alcohol and concluded that more frequent skin disinfection would be required in summer to maintain effective control of skin bacteria 14 . In our patients no significant difference was found with regard to the season. It is possible that the use of plastic coated mattresses in our institution has contributed to this problem, as many patients have been observed to develop a generalized folliculitis involving skin areas in contact with the mattress.
The importance of local signs of catheter site infection has been recently examined in a paper by Darchy et al 15 , concluding that in ICU patients the presence of erythema and local discharge together was strongly predictive of local and epidural catheter infection, but that erythema alone was not a predictor of catheter colonization. The absence of the two local signs had a negative predictive value of 100% for catheter colonization. They concluded that erythema alone was not a sufficient reason for catheter removal. This is supported in an abstract published by Beilby et al in which the positive predictive value of site inflammation for site infection was 35.6%. Catheter contamination was also identified as the source of problems in establishing a causal relationship between site infection and catheter infection 16 .
Unfortunately we did not separate the group with erythema alone from those with erythema and local discharge, and so our figure of 5.3% is thus most likely an overestimation of skin site infection. However, as the possible consequences of epidural space infection may be so devastating, the most conservative practice of removing the catheter in the presence of any sign of local inflammation can be recommended for most patients. We noted that there was a highly significant difference in the incidence of these signs after day 3, a period in which the benefits of epidural analgesia over other forms of postoperative analgesia become less clearly defined for the majority of patients. The decision to continue with epidural analgesia beyond four days should be made after considering the risk/benefit ratio for each individual patient, especially in the presence of isolated site erythema. The importance of close surveillance of epidural catheter sites cannot be overstated.
The three cases of intravenous catheter migration caused no systemic problems as would be expected from low concentrations of bupivacaine and fentanyl, and the one subarachnoid catheter was detected early because of ascending motor block.
Hypotension occurred in 2.8% of our series compared to 6.6% and 3% for Scott 6 and de Leon-Casasola 7 respectively. One patient experienced severe hypotension and required intubation and adrenaline, but this was associated with induction of the block rather than its maintenance and occurred whilst the patient was in the recovery unit. The patient recovered after unrecognised hypovolaemia was corrected. The unmasking of mild hypovolaemia in postoperative patients by regimens which include local anaesthetic, provided it is rapidly corrected, could be considered to be a useful side-effect rather than a problem for most patients. The potential for hypotension and its possible sequelae justify the routine monitoring of blood pressure, especially after bolus administration.
Respiratory depression is a major concern in the use of the epidural analgesia. Clearly this is more of a problem with lipid insoluble drugs such as morphine, but does also occur with the use of fentanyl [6] [7] [8] . In our series there were four episodes of respiratory depression (0.32%) all of which were treated with naloxone according to the protocol outlined in the standing orders. There were ten episodes of sedation (0.77%). We acknowledge that spot oximetry is not adequate to detect periods of acute desaturation related to the use of opioids. Continuous oximetry is not available on the wards in our institution. Further we have thus far been unable to gain acceptance of the consequent requirement for supplemental oxygen in all patients receiving opioids.
Scott et al 6 found a 1.2% incidence of respiratory depression although only four of the 12 patients required naloxone, and a 7.4% incidence of sedation, and de Leon-Casasola 7 reported incidences of 0.07% for respiratory depression and sedation. The difficulties in comparing respiratory depression and sedation between studies was noted by both these authors and may explain some of the differences. In addition we used lower concentrations of fentanyl in our standard solutions than in the initial part of Scott's study. Although the infusion rates were documented, we have not analysed them. However our standard protocols do not allow for rates in excess of those described in Scott's paper.
Three of the four episodes of respiratory depression in our study were associated with sedation and all occurred at the time of infusion. There was no episode of delayed respiratory depression, although two of the episodes occurred in patients receiving epidural morphine infusions. All cases were able to be managed in the ward and no patient required respiratory support as a result of epidural analgesia. The incidence of respiratory depression using PCA morphine quoted by Schug 8 was 1.2% for slight depression and 0.6% for severe respiratory depression.
The five cases of ward error recorded were all in the administration of the solution rather than its preparation. On two occasions a bolus of 200 ml of 0.125% bupivacaine and 500 µg of fentanyl was given by neglecting to set a limit on the infusion pump when it had been intended to give a 5 to 10 ml bolus from the Polybag. In each case the entire contents of the Polybag was infused via a thoracic catheter. One patient developed a very high sensory block and required supplemental oxygen, and the other devel-oped mild hypotension which was treated by intravenous fluid loading. The other cases were similar but the volumes infused were much smaller, and there were no systemic effects. These cases all resulted from failure to adhere to the policies of the APS for bolus administration. These overdoses may have been prevented if the APS policy was to use manually delivered boluses from a syringe driver system, or if a burette was incorporated in the delivery system. However these options were avoided for specific reasons. Syringe pumps require either frequent changes, each with the possibility of error, or the use of a sideline to allow connection to the reservoir bag. The dangers of such systems have been highlighted previously 17 . Similarly we are concerned that the use of a burette in the giving set poses considerable danger as it provides a port for injection of drugs not intended for epidural infusion. The choice of equipment for delivery of epidural infusions currently involves a degree of compromise.
The work of Kehlet et al has focused attention on outcomes as well as quality of analgesia and the importance of early mobilization has been emphasized [18] [19] [20] . The incidence of leg weakness of 8.4% in our study is therefore of concern, and contrasts with the 3% reported by Scott et al 6 . The incidence has been reduced in the latter part of the study by increased awareness amongst the anaesthetists of the importance of inserting the epidural catheter at the appropriate dermatomal level, and by avoiding the use of 0.25% bupivacaine where possible, particularly for lumbar and low thoracic applications.
Pruritus was observed in 2.4 % of our episodes but this is probably under-reporting, in that only cases requiring treatment or change of infusion were recorded. There was a significant difference between the three main treatment groups with respect to the incidence of pruritus. This may be compared to the 10.3% rate reported by Scott 6 which is surprising because none of his patients received morphine, as compared with 114 of our patients. Two large series of patients receiving epidural morphine have reported incidences of 11% and 25% 21, 22 . de Leon-Casasola 7 who infused the same concentration of morphine as used in our patients reported an overall incidence of 22% and a 4% incidence of pruritus requiring treatment.
Nausea and vomiting was recorded in 2.8% of our group as opposed to 3.1% for Scott 6 and 22% for de Leon-Casasola 7 . Ready 22 also found an incidence of 29% in his series of patients receiving epidural morphine. Again these discrepancies may reflect differences in the reporting of this side-effect. Certainly in our series there was no significant difference between the morphine group and the two fentanyl containing groups.
At least in our hospital it appears that it is also safe for nursing staff to prepare solutions for epidural infusion in the ward, although we acknowledge that, depending on the endpoint chosen, our study may lack the power to demonstrate this.
Thus there are a significant number of complications associated with postoperative epidural analgesia which must be weighed up in the decision to use the technique. In our series 20.1% of patients required an alternative technique or reinsertion of the epidural catheter within 48 hours, the period where postoperative pain has been considered to be most severe 23 . Nearly half of these failures were due to accidental dislodgement of the epidural catheter and further research is required to reduce this figure. In addition, more work is required to define the patient groups where epidural analgesia can be shown to result in improved outcome, so that a more informed decision to utilize this form of postoperative analgesia can be made.
Epidural analgesia can be used safely in the ward setting provided there are appropriate standing orders in place and access to skilled assistance at all times. In most cases this will be best provided by an Acute Pain Service.
